AU2003226753B2 - Statin therapy for enhancing cognitive maintenance - Google Patents
Statin therapy for enhancing cognitive maintenance Download PDFInfo
- Publication number
- AU2003226753B2 AU2003226753B2 AU2003226753A AU2003226753A AU2003226753B2 AU 2003226753 B2 AU2003226753 B2 AU 2003226753B2 AU 2003226753 A AU2003226753 A AU 2003226753A AU 2003226753 A AU2003226753 A AU 2003226753A AU 2003226753 B2 AU2003226753 B2 AU 2003226753B2
- Authority
- AU
- Australia
- Prior art keywords
- statin
- galantamine
- dementia
- amount
- examples
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36928502P | 2002-04-02 | 2002-04-02 | |
| US60/369,285 | 2002-04-02 | ||
| PCT/EP2003/003324 WO2003082298A1 (en) | 2002-04-02 | 2003-03-28 | Statin therapy for enhancing cognitive maintenance |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003226753A1 AU2003226753A1 (en) | 2003-10-13 |
| AU2003226753B2 true AU2003226753B2 (en) | 2007-06-28 |
Family
ID=28675573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003226753A Ceased AU2003226753B2 (en) | 2002-04-02 | 2003-03-28 | Statin therapy for enhancing cognitive maintenance |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1492539B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005525391A (cg-RX-API-DMAC7.html) |
| KR (1) | KR100986194B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN100528164C (cg-RX-API-DMAC7.html) |
| AT (1) | ATE331523T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003226753B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR0308293A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2480275C (cg-RX-API-DMAC7.html) |
| CY (1) | CY1105545T1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE60306503T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1492539T3 (cg-RX-API-DMAC7.html) |
| EA (1) | EA013069B1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2268393T3 (cg-RX-API-DMAC7.html) |
| IL (2) | IL164317A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA04009535A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20044698L (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ536111A (cg-RX-API-DMAC7.html) |
| PL (1) | PL211160B1 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1492539E (cg-RX-API-DMAC7.html) |
| UA (1) | UA79605C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003082298A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1603548A4 (en) * | 2003-02-05 | 2007-10-10 | Myriad Genetics Inc | METHOD AND COMPOSITION FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES |
| EP1737539A1 (en) * | 2004-04-14 | 2007-01-03 | Warner-Lambert Company LLC | Therapeutic combination for treatment of alzheimers disease |
| EP1604686A1 (en) * | 2004-06-08 | 2005-12-14 | Axonyx, Inc. | Use of phenserine and a HMG CoA reductase inhibitor for delaying Alzheimer's disease progression |
| GB0607946D0 (en) * | 2006-04-21 | 2006-05-31 | Minster Res The Ltd | Mono and combination therapy |
| AU2007299726A1 (en) * | 2006-09-22 | 2008-03-27 | Braincells, Inc. | Combination comprising an HMG-COA reductase inhibitor and a second neurogenic agent for treating a nervous system disorder and increasing neurogenesis |
| TWI432195B (zh) | 2007-10-03 | 2014-04-01 | Kowa Co | 神經細胞死亡抑制劑 |
| US20160303146A1 (en) * | 2013-12-13 | 2016-10-20 | David A. TABACZYNSKI | Inhibition of isoprenoid biosynthetic pathways to treat neuroinflammatory disorders |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW506836B (en) * | 1996-06-14 | 2002-10-21 | Janssen Pharmaceutica Nv | Fast-dissolving galanthamine hydrobromide tablet |
-
2003
- 2003-03-28 DK DK03745196T patent/DK1492539T3/da active
- 2003-03-28 BR BR0308293-8A patent/BR0308293A/pt not_active IP Right Cessation
- 2003-03-28 KR KR1020047013127A patent/KR100986194B1/ko not_active Expired - Fee Related
- 2003-03-28 UA UA20040806803A patent/UA79605C2/uk unknown
- 2003-03-28 EA EA200401295A patent/EA013069B1/ru not_active IP Right Cessation
- 2003-03-28 IL IL16431703A patent/IL164317A0/xx unknown
- 2003-03-28 DE DE60306503T patent/DE60306503T2/de not_active Expired - Lifetime
- 2003-03-28 ES ES03745196T patent/ES2268393T3/es not_active Expired - Lifetime
- 2003-03-28 MX MXPA04009535A patent/MXPA04009535A/es active IP Right Grant
- 2003-03-28 CN CNB038073854A patent/CN100528164C/zh not_active Expired - Fee Related
- 2003-03-28 AT AT03745196T patent/ATE331523T1/de active
- 2003-03-28 CA CA2480275A patent/CA2480275C/en not_active Expired - Fee Related
- 2003-03-28 PT PT03745196T patent/PT1492539E/pt unknown
- 2003-03-28 JP JP2003579835A patent/JP2005525391A/ja active Pending
- 2003-03-28 WO PCT/EP2003/003324 patent/WO2003082298A1/en not_active Ceased
- 2003-03-28 EP EP03745196A patent/EP1492539B1/en not_active Expired - Lifetime
- 2003-03-28 PL PL371551A patent/PL211160B1/pl unknown
- 2003-03-28 NZ NZ536111A patent/NZ536111A/xx not_active IP Right Cessation
- 2003-03-28 AU AU2003226753A patent/AU2003226753B2/en not_active Ceased
-
2004
- 2004-09-28 IL IL164317A patent/IL164317A/en not_active IP Right Cessation
- 2004-10-29 NO NO20044698A patent/NO20044698L/no not_active Application Discontinuation
-
2006
- 2006-09-27 CY CY20061101397T patent/CY1105545T1/el unknown
Non-Patent Citations (2)
| Title |
|---|
| Fulton & Benfield, Drugs Aging, 1996, 9(1):60-5 * |
| Jick et al., Lancet, 2001, 357:562 * |
Also Published As
| Publication number | Publication date |
|---|---|
| PL211160B1 (pl) | 2012-04-30 |
| CN100528164C (zh) | 2009-08-19 |
| PT1492539E (pt) | 2006-11-30 |
| KR100986194B1 (ko) | 2010-10-07 |
| DE60306503T2 (de) | 2007-06-21 |
| DK1492539T3 (da) | 2006-10-30 |
| PL371551A1 (en) | 2005-06-27 |
| CY1105545T1 (el) | 2010-07-28 |
| IL164317A0 (en) | 2005-12-18 |
| AU2003226753A1 (en) | 2003-10-13 |
| NZ536111A (en) | 2006-03-31 |
| NO20044698L (no) | 2004-10-29 |
| ATE331523T1 (de) | 2006-07-15 |
| EA200401295A1 (ru) | 2005-02-24 |
| DE60306503D1 (de) | 2006-08-10 |
| HK1079688A1 (zh) | 2006-04-13 |
| JP2005525391A (ja) | 2005-08-25 |
| CN1642555A (zh) | 2005-07-20 |
| MXPA04009535A (es) | 2005-01-25 |
| EP1492539B1 (en) | 2006-06-28 |
| UA79605C2 (en) | 2007-07-10 |
| EP1492539A1 (en) | 2005-01-05 |
| ES2268393T3 (es) | 2007-03-16 |
| BR0308293A (pt) | 2004-12-28 |
| KR20040096608A (ko) | 2004-11-16 |
| IL164317A (en) | 2010-04-29 |
| EA013069B1 (ru) | 2010-02-26 |
| CA2480275C (en) | 2011-08-16 |
| WO2003082298A1 (en) | 2003-10-09 |
| CA2480275A1 (en) | 2003-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12496300B2 (en) | Methods of treating acute depression and anxiety | |
| US11013712B2 (en) | Methods of treating insomnia using a combination therapy of low-dose doxepin and zolpidem | |
| US20030060423A1 (en) | Co-therapy for the treatment of dementia and associated behavioral manifestations comprising anticonvulsant derivatives and acetylcholinesterase inhibitors | |
| US20080182890A1 (en) | Methods of using low-dose doxepin for the improvement of sleep | |
| AU780817B2 (en) | Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone | |
| CA2480275C (en) | Statin therapy for enhancing cognitive maintenance | |
| JP2011512399A (ja) | 卵巣癌を治療するための、パクリタキセルを含む配合剤 | |
| US20050222122A1 (en) | Statin therapy for enhancing cognitive maintenance | |
| AU2004317129A1 (en) | Combined pharmaceutical composition for the inhibition of the decline of cognitive functions | |
| EP1663247B1 (en) | Use of oxcarbazepine for the improvement of sleep in patients suffering from chronic pain | |
| JP2006522050A (ja) | 認知症患者における激越の処置のためのカルバマゼピン誘導体の使用 | |
| HK1079688B (en) | Statin product for enhancing cognitive maintenance | |
| ZA200601502B (en) | Use of oxcarbazepine for the treatment of diabetic neuropathic pain and improvement of sleep | |
| AU2002323467A1 (en) | Treatment of dementia and memory disorders with anticonvulsants and acetylcholinesterase inhibitors | |
| KR20060130689A (ko) | 인지 기능의 감퇴를 억제하기 위한 혼합 약제 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |